Full-Time

Director – Launch Excellence Program Manager

Global Oncology

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$174.5k - $274.2k/yr

+ Short-term Incentives + Long-term Incentives

Senior, Expert

Cambridge, MA, USA

This position is currently classified as 'hybrid' in accordance with Takeda's Hybrid and Remote Work policy.

Category
Project Management
Business & Strategy
Required Skills
Risk Management
Requirements
  • Bachelor’s degree required; MBA and/or PMI certification strongly desired
  • 6+ years proven experience managing complex cross-functional initiatives in advanced program or project management role within a commercialization environment
  • Demonstrated success in commercial planning and launching products, including driving effective launch strategy, and identifying and implementing best practices
  • Experience managing competing priorities and ensuring timely delivery of project tasks, preferably within a product launch
  • Outstanding working knowledge of change management principles and performance evaluation processes
  • Able to thrive in a highly dynamic, fast paced, continuously changing global environment with minimal oversight/direction
  • Prior experience either as consultants to the pharmaceutical and medical devices sectors, or who have experience working directly for a commercial pharmaceutical organization participating in the delivery of complex projects and delivering impactful results.
Responsibilities
  • Lead large cross-functional, cross-regional launch teams to design and execute implementation plans for Global launch brands of high strategic importance to the GOBU
  • Ensure optimal set up and implementation of GOBU launch excellence framework, provide efficient launch excellence leadership, ensure effective issue and risk identification and resolution, and support resource management planning to realize program strategic objectives in line with launch timelines
  • Collaborate closely with the Oncology Leadership Team and cross-functional teams to implement launch operating and governance model across Global and Regional commercial teams and other collaborating functions (e.g. R&D) in a highly matrixed environment
  • Drive the implementation of program and project management processes, systems, and governance in alignment with the GOBU Launch Excellence framework
  • Collaborate with cross-functional launch brand teams, Strategy & Operations, and PMO teams to develop and refine best practices, ensuring alignment and consistency across initiatives
  • Collaborate with launch brand teams to develop and manage key launch deliverables, including launch plans, presentations, and essential documentation to track and memorialize launch progress
  • Foster a high-performing launch team by defining and clarifying roles and responsibilities for team members while implementing best practices and tools to support efficient and effective ways of working and project management
  • Collaborate with launch brand team leads to design and executing stakeholder communication plans, ensuring cross-functional teams and leadership are consistently informed of key updates, potential risks and opportunities
  • Prepare, facilitate, and proactively manage execution of actions resulting from launch reviews
  • Collaborates with launch teams to assess risks and develop effective mitigation strategies
  • Act as the internal subject matter expert (SME) on GOBU Launch Excellence, driving the pull-through of the launch excellence framework as applicable for launch programs
  • Develop and maintain launch tracking and communication tools such as dashboards or reports
  • Design and facilitate planning and scenario workshops to ensure readiness and identify potential challenges
  • Ensure launch teams accountability to deliver on commitments.
Desired Qualifications
  • Deep understanding of life sciences or adjacent industry
  • Results / action-oriented ability to manage multiple concurrent large-scale initiatives
  • Excellent communication and stakeholder management skills, with ability to influence senior leaders
  • Critical thinker and creative problem solver with high learning agility
  • Strong leadership and management of large matrixed cross-functional teams
  • Highly developed executive level communications skills (written/verbal) with organizational and interpersonal savvy
  • Exceptional skills with Smartsheet, MS Project, Visio, and MS Office Suite (Word, Excel, PowerPoint, Outlook)

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.